Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of Postoperative Inpatient Ketorolac and Outpatient Naproxen Use Following Elective Lumbar Spine Fusion

NCT06484192 is registered in ClinicalTrials.gov with Rothman Institute Orthopaedics as lead sponsor.

NCT NCT06484192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06484192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of Postoperative Inpatient Ketorolac and Outpatient Naproxen Use Following Elective Lumbar Spine Fusion
Lead sponsor
Rothman Institute Orthopaedics
Phase
Phase 4
Overall status
Unknown status
Start date
June 28, 2024
Completion date
June 30, 2025
Enrollment
428 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsaid (non-steroidal anti-inflammatory drug), postoperative pain, spine fusion